Clinical Trials Logo

Anal Cancer Patients clinical trials

View clinical trials related to Anal Cancer Patients.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06364579 Recruiting - Clinical trials for Anal Cancer Patients

Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).

PROACT
Start date: March 28, 2024
Phase:
Study type: Observational

Radiochemotherapy is the standard treatment for neoplasms of the anal canal with excellent rates of local control and preservation of the anal sphincter. However, patients may experience a deterioration of quality of life related to sequelae of the treatment particularly at intestinal, anal sphincter and sexual level. Few studies to date have documented patient-reported outcomes (PROs) in this area. The aim of this observational study is to verify the quality of life (QOL) of the patients by means of self-completed questionnaires.